Phase one vaccine trials often include dose escalation, starting with very small doses and gradually increasing the dose to ensure safety and assess immune response.

“we're not talking about 10 000 people and these are often done with a little bit of a dose escalation built in so maybe the first 10 people are going to get a really really small dose we make sure nothing catastrophic happens we then escalate the next 10 etc right they're dose ranging trials”